Song Z - Search Results

1

Comparison of efficacy and safety of second- and third-generation TKIs for non-small-cell lung cancer with uncommon EGFR mutations.

Hao Y, Xu M, Jin J, Si J, Xu C, Song Z. Hao Y, et al. Among authors: song z. Cancer Med. 2023 Aug;12(15):15903-15911. doi: 10.1002/cam4.6229. Epub 2023 Jun 12. Cancer Med. 2023. PMID: 37306192 Free PMC article.

2

[Analysis of the efficacy and survival of third-line treatment in advanced non-small cell lung cancer].

Shao L, Song Z, Hu L, Xie F, Lou G, Hong W, Gu C, Hong D, Lin B, Zhang Y. Shao L, et al. Among authors: song z. Zhongguo Fei Ai Za Zhi. 2012 Jun;15(6):369-74. doi: 10.3779/j.issn.1009-3419.2012.06.08. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22681924 Free PMC article. Chinese.

3

[Efficacy of icotinib for advanced non-small cell lung cancer patients with EGFR status identified].

Song Z, Yu X, Cai J, Shao L, Lin B, He C, Zhang B, Zhang Y. Song Z, et al. Zhongguo Fei Ai Za Zhi. 2013 Mar;16(3):138-43. doi: 10.3779/j.issn.1009-3419.2013.03.04. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23514942 Free PMC article. Chinese.

4

[Relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment of advanced non-small cell lung cancer with tyrosine kinase inhibitor].

Zheng L, Lin B, Song Z, Xie F, Hong W, Feng J, Shao L, Zhang Y. Zheng L, et al. Among authors: song z. Zhongguo Fei Ai Za Zhi. 2013 Dec;16(12):632-8. doi: 10.3779/j.issn.1009-3419.2013.12.03. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24345487 Free PMC article. Clinical Trial. Chinese.

5

Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy.

Shao L, Zhang B, He C, Lin B, Song Z, Lou G, Yu X, Zhang Y. Shao L, et al. Among authors: song z. Chin Med J (Engl). 2014;127(2):266-71. Chin Med J (Engl). 2014. PMID: 24438614

6

[Joint serum tumor markers serve as survival predictive model of erlotinib in the treatment of recurrent non-small cell lung cancer].

Shao L, Hong W, Zheng L, He C, Zhang B, Xie F, Song Z, Lou G, Zhang Y. Shao L, et al. Among authors: song z. Zhongguo Fei Ai Za Zhi. 2014 May;17(5):391-400. doi: 10.3779/j.issn.1009-3419.2014.05.05. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24854556 Free PMC article. Chinese.

7

[Progress in Tissue Specimens Alternative for the Driver Genes Testing of Non-small Cell Lung Cancer].

Sun Y, Song Z. Sun Y, et al. Among authors: song z. Zhongguo Fei Ai Za Zhi. 2015 Jun;18(6):387-90. doi: 10.3779/j.issn.1009-3419.2015.06.10. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26104897 Free PMC article. Review. Chinese.

8

Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations.

Chen D, Song Z, Cheng G. Chen D, et al. Among authors: song z. Onco Targets Ther. 2016 Jul 8;9:4181-6. doi: 10.2147/OTT.S108242. eCollection 2016. Onco Targets Ther. 2016. PMID: 27468240 Free PMC article.

9

Patients with ROS1 rearrangement-positive non-small-cell lung cancer benefit from pemetrexed-based chemotherapy.

Song Z, Su H, Zhang Y. Song Z, et al. Cancer Med. 2016 Oct;5(10):2688-2693. doi: 10.1002/cam4.809. Epub 2016 Aug 20. Cancer Med. 2016. PMID: 27544536 Free PMC article.

10

Mutation and prognostic analyses of PIK3CA in patients with completely resected lung adenocarcinoma.

Song Z, Yu X, Zhang Y. Song Z, et al. Cancer Med. 2016 Oct;5(10):2694-2700. doi: 10.1002/cam4.852. Epub 2016 Aug 23. Cancer Med. 2016. PMID: 27554588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,081 results

Search Page

Filters